Serum Institute of India and University of Oxford Strike Landmark Licensing Agreement for Meningitis-B Vaccine
Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines.